91 related articles for article (PubMed ID: 22356681)
21. [Differential proteomic analysis and function study of human prostate carcinoma cells with different osseous metastatic tendency].
Song DX; Chen AM; Guo FJ; Liao H; Xie BZ; Zhu B; Chen C
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1197-201. PubMed ID: 18844116
[TBL] [Abstract][Full Text] [Related]
22. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
[TBL] [Abstract][Full Text] [Related]
23. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
Siclari VA; Guise TA; Chirgwin JM
Cancer Metastasis Rev; 2006 Dec; 25(4):621-33. PubMed ID: 17165131
[TBL] [Abstract][Full Text] [Related]
24. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
25. Studies of osteotropism on both sides of the breast cancer-bone interaction.
Moreau J; Anderson KM; Mauney JR; Kaplan D; Rosenblatt M
Ann N Y Acad Sci; 2007 Nov; 1117():328-44. PubMed ID: 17584985
[TBL] [Abstract][Full Text] [Related]
26. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of breast cancer bone metastasis.
Zhang Y; Ma B; Fan Q
Cancer Lett; 2010 Jun; 292(1):1-7. PubMed ID: 20006425
[TBL] [Abstract][Full Text] [Related]
28. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
29. A mouse model of human breast cancer metastasis to human bone.
Kuperwasser C; Dessain S; Bierbaum BE; Garnet D; Sperandio K; Gauvin GP; Naber SP; Weinberg RA; Rosenblatt M
Cancer Res; 2005 Jul; 65(14):6130-8. PubMed ID: 16024614
[TBL] [Abstract][Full Text] [Related]
30. Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem.
Pluijm G; Löwik C; Papapoulos S
Cancer Treat Rev; 2000 Feb; 26(1):11-27. PubMed ID: 10660489
[TBL] [Abstract][Full Text] [Related]
31. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
32. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
[TBL] [Abstract][Full Text] [Related]
33. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
[TBL] [Abstract][Full Text] [Related]
34. Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro.
Bucciarelli E; Sidoni A; Bellezza G; Cavaliere A; Brachelente G; Costa G; Chaplet M; Castronovo V; Bellahcène A
Breast Cancer Res Treat; 2007 Sep; 105(1):95-104. PubMed ID: 17136477
[TBL] [Abstract][Full Text] [Related]
35. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
Li J; Gromov P; Gromova I; Moreira JM; Timmermans-Wielenga V; Rank F; Wang K; Li S; Li H; Wiuf C; Yang H; Zhang X; Bolund L; Celis JE
Proteomics; 2008 Dec; 8(23-24):5038-52. PubMed ID: 19003862
[TBL] [Abstract][Full Text] [Related]
36. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
[TBL] [Abstract][Full Text] [Related]
37. Decorin suppresses bone metastasis in a breast cancer cell line.
Araki K; Wakabayashi H; Shintani K; Morikawa J; Matsumine A; Kusuzaki K; Sudo A; Uchida A
Oncology; 2009; 77(2):92-9. PubMed ID: 19590249
[TBL] [Abstract][Full Text] [Related]
38. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
Buijs JT; van der Horst G; van den Hoogen C; Cheung H; de Rooij B; Kroon J; Petersen M; van Overveld PG; Pelger RC; van der Pluijm G
Oncogene; 2012 Apr; 31(17):2164-74. PubMed ID: 21996751
[TBL] [Abstract][Full Text] [Related]
39. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
[TBL] [Abstract][Full Text] [Related]
40. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]